Macrogenics reported $218.2M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US $ 19322M 802M
AstraZeneca AZN:LN 20.92B 1.73B
Biogen BIIB:US $ 9740.9M 1825M
Bristol Myers Squibb BMY:US $ 30186M 65M
Cerulean Pharma CERU:US $ 47.82M 7.48M
Daiichi Sankyo 4568:JP Y 1367130M 21859M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Epizyme EPZM:US $ 228.71M 22.66M
Genmab GEN:DC 23.18B 439M
Geron GERN:US $ 175.92M 11.28M
Gilead Sciences GILD:US $ 13705M 1076M
Immunogen IMGN:US $ 373.87M 82.84M
Karyopharm Therapeutics KPTI:US $ 242.45M 34.09M
Macrogenics MGNX:US $ 218.2M 61.36M
Mirati Therapeutics MRTX:US $ 1202.93M 140.19M
Puma Biotechnology PBYI:US $ 114.28M 3.29M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Seattle Genetics SGEN:US $ 2778.66M 7.4M
Xencor XNCR:US $ 585.94M 79.97M